The Precision Peptide Genetic Test identifies metabolic vulnerabilities that dietary or lifestyle changes alone cannot address, giving you a complete picture of your biological barriers
By reducing appetite and helping people feel satisfied on smaller portions, GLP-1 medicines can support weight loss when combined with lifestyle changes
Combining alcohol with tirzepatide also increases the risk of pancreatitis and kidney damage or acute kidney injury
The FDA provided a grace period: 503A pharmacies had until February 18, 2025, and 503B outsourcing facilities until March 19, 2025
References: (1) Heffernan MA, Thorburn AW, Fam B, Summers R, Conway-Campbell B, Waters MJ, Ng FM